| Serial Number | 77602824 |
| Word Mark | B BEAUFORT |
| Filing Date | Wednesday, October 29, 2008 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, March 3, 2017 |
| Registration Number | 3825880 |
| Registration Date | Tuesday, July 27, 2010 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, July 14, 2009 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the letter "B" written in a circle with the word "Beaufort" written to the right of the circle and an arc appearing beneath the letter "B" and the word "Beaufort". |
| Goods and Services | Regulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management |
| Goods and Services | Consulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals |
| Goods and Services | Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, devices and biologics |
| Goods and Services | Legal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validation, namely, regulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvement, namely, providing independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 3, 2017 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, June 25, 2009 |
| First Use In Commerce Date | Thursday, June 25, 2009 |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 3, 2017 |
| Primary Code | 040 |
| First Use Anywhere Date | Thursday, June 25, 2009 |
| First Use In Commerce Date | Thursday, June 25, 2009 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 3, 2017 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, June 25, 2009 |
| First Use In Commerce Date | Thursday, June 25, 2009 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 3, 2017 |
| Primary Code | 045 |
| First Use Anywhere Date | Thursday, June 25, 2009 |
| First Use In Commerce Date | Thursday, June 25, 2009 |
| Party Name | BEAUFORT, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | NORFOLK, VA 23510 |
| Party Name | BEAUFORT, LLC |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | NORFOLK, VA 23510 |
| Party Name | Beaufort Advisors, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Norfolk, VA 23510 |
| Party Name | Beaufort Advisors, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Norfolk, VA 23510 |
| Event Date | Event Description |
| Friday, March 3, 2017 | CANCELLED SEC. 8 (6-YR) |
| Monday, June 20, 2016 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, June 20, 2016 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, July 27, 2010 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, June 19, 2010 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, June 18, 2010 | LAW OFFICE REGISTRATION REVIEW COMPLETED |
| Friday, June 18, 2010 | ASSIGNED TO LIE |
| Thursday, June 3, 2010 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Wednesday, May 19, 2010 | ASSIGNED TO EXAMINER |
| Monday, April 26, 2010 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, April 8, 2010 | USE AMENDMENT FILED |
| Monday, April 26, 2010 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, April 8, 2010 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, April 7, 2010 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, April 6, 2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 2, 2010 | EXTENSION 1 GRANTED |
| Friday, April 2, 2010 | EXTENSION 1 FILED |
| Friday, April 2, 2010 | TEAS EXTENSION RECEIVED |
| Tuesday, October 6, 2009 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, July 14, 2009 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 24, 2009 | NOTICE OF PUBLICATION |
| Monday, June 8, 2009 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, June 8, 2009 | ASSIGNED TO LIE |
| Friday, June 5, 2009 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 2, 2009 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 2, 2009 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 2, 2009 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, February 3, 2009 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 3, 2009 | NON-FINAL ACTION E-MAILED |
| Tuesday, February 3, 2009 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 27, 2009 | ASSIGNED TO EXAMINER |
| Tuesday, November 4, 2008 | NOTICE OF DESIGN SEARCH CODE MAILED |
| Monday, November 3, 2008 | NEW APPLICATION ENTERED IN TRAM |